Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:GTBP
일자시간출처헤드라인심볼기업
2025/02/0723:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:GTBPGT Biopharma Inc
2025/01/2722:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:GTBPGT Biopharma Inc
2025/01/2721:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2024/12/2407:23Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GTBPGT Biopharma Inc
2024/11/2806:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2024/11/2123:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2024/11/1506:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
2024/10/2210:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
2024/10/1800:15Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GTBPGT Biopharma Inc
2024/09/1705:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2024/06/1805:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
2024/06/1405:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
2024/06/0806:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2024/05/2409:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
2024/05/2319:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GTBPGT Biopharma Inc
2024/05/2319:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2024/05/1606:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
2024/02/1504:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
2024/02/0202:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2023/12/2205:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2023/12/0507:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2023/11/0707:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
2023/11/0707:23Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
2023/11/0707:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
2023/11/0122:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
2023/10/2806:23Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
2023/09/2000:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
2023/08/2305:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
2023/08/1608:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
2023/08/1608:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
 검색 관련기사 보기:NASDAQ:GTBP